Cargando…
Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
With an estimated 25% of the global population infected with Mycobacterium tuberculosis (Mtb), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatment is largely uncharacterized, and antibody profiling could provide insights into disease res...
Autores principales: | Grace, Patricia S., Dolatshahi, Sepideh, Lu, Lenette L., Cain, Adam, Palmieri, Fabrizio, Petrone, Linda, Fortune, Sarah M., Ottenhoff, Tom H. M., Lauffenburger, Douglas A., Goletti, Delia, Joosten, Simone A., Alter, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287567/ https://www.ncbi.nlm.nih.gov/pubmed/34290702 http://dx.doi.org/10.3389/fimmu.2021.679973 |
Ejemplares similares
-
Antibody glycosylation in inflammation, disease and vaccination
por: Alter, Galit, et al.
Publicado: (2018) -
Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis
por: Lu, Lenette L, et al.
Publicado: (2020) -
Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment
por: Joosten, Simone A., et al.
Publicado: (2016) -
Tuberculosis Biomarkers: From Diagnosis to Protection
por: Goletti, Delia, et al.
Publicado: (2016) -
A Helicopter Perspective on TB Biomarkers: Pathway and Process Based Analysis of Gene Expression Data Provides New Insight into TB Pathogenesis
por: Joosten, Simone A., et al.
Publicado: (2013)